NeuroOne Medical Technolo...

NASDAQ: NMTC · Real-Time Price · USD
0.62
0.00 (0.65%)
At close: May 23, 2025, 3:59 PM
0.59
-5.95%
After-hours: May 23, 2025, 05:15 PM EDT

Company Description

NeuroOne Medical Technologies Corporation operates as a medical technology company.

The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders.

It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode.

The company is based in Eden Prairie, Minnesota.

NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation logo
Country United States
IPO Date Mar 15, 2018
Industry Medical - Devices
Sector Healthcare
Employees 17
CEO David A. Rosa M.D.

Contact Details

Address:
7599 Anagram Drive
Eden Prairie, Minnesota
United States
Website https://n1mtc.com

Stock Details

Ticker Symbol NMTC
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001500198
CUSIP Number 64130M209
ISIN Number US64130M2098
Employer ID 27-0863354
SIC Code 3841

Key Executives

Name Position
David A. Rosa M.D. President, Chief Executive Officer & Director
Christopher R. Volker CFA Chief Operating Officer
Ronald W. McClurg Chief Financial Officer
Steven Mertens Chief Technology Officer
Dr. Parag G. Patil M.D., Ph.D. Chief Medical Advisor
Hijaz Haris Vice President of Marketing
Mark Christianson Co-Founder, Business Development Director & Medical Sales Liaison

Latest SEC Filings

Date Type Title
May 21, 2025 4 Filing
May 15, 2025 SCHEDULE 13G/A [Amend] Filing
May 13, 2025 8-K Current Report
May 13, 2025 10-Q Quarterly Report
May 09, 2025 8-K Current Report
May 09, 2025 SCHEDULE 13G/A [Amend] Filing
Apr 21, 2025 4 Filing
Apr 21, 2025 4 Filing
Apr 21, 2025 4 Filing
Apr 21, 2025 4 Filing